Evidence map›Paper›PMID 27251306›Full record

ArticleScientific reports2016

TLR9-ERK-mTOR signaling is critical for autophagic cell death induced by CpG oligodeoxynucleotide 107 combined with irradiation in glioma cells.

Xiaoli Li, Yanyan Cen, Yongqing Cai, Tao Liu, Huan Liu, Guanqun Cao, Dan Liu, Bin Li, Wei Peng, Jintao Zou and 3 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Involvement of Cathepsins in Innate and Adaptive Immune Responses in Periodontitis.Evidence-based complementary and alternative medicine : eCAM · 2020
    Review
  8. Article
  9. Article
  10. Article
  11. Involvement of P2XBioMed research international · 2018
    Article
  12. Role of autophagy in regulating the radiosensitivity of tumor cells.Journal of cancer research and clinical oncology · 2017
    Review
  13. Stimulating Innate Immunity to Enhance Radiation Therapy-Induced Tumor Control.International journal of radiation oncology, biology, physics · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Xiaoli LiDepartment of Pharmacology, College of Pharmacy, the Third Military Medical University, Chongqing 400038, China.
Yanyan CenDepartment of Pharmacology, College of Pharmacy, the Third Military Medical University, Chongqing 400038, China.
Yongqing CaiDepartment of Pharmacy, Institute of Surgery Research, Daping Hospital, the Third Military Medical University, Chongqing 400042, China.
Tao LiuDepartment of Pharmacology, College of Pharmacy, the Third Military Medical University, Chongqing 400038, China.
Huan LiuDepartment of Pharmacology, College of Pharmacy, the Third Military Medical University, Chongqing 400038, China.
Guanqun CaoDepartment of Pharmacology, College of Pharmacy, the Third Military Medical University, Chongqing 400038, China.
Dan LiuDepartment of Pharmacology, College of Pharmacy, the Third Military Medical University, Chongqing 400038, China.
Bin LiDepartment of Pharmacology, College of Pharmacy, the Third Military Medical University, Chongqing 400038, China.
Wei PengDepartment of Pharmacology, College of Pharmacy, the Third Military Medical University, Chongqing 400038, China.
Jintao ZouCompany 18th, College of Pharmacy, the Third Military Medical University, Chongqing 400038, China.
Xueli PangDepartment of Oncology, Southwest Hospital, the Third Military Medical University, Chongqing 400038, China.
Jiang ZhengMedical Research Center, Southwestern Hospital, the Third Military Medical University, Chongqing 400038, China.
Hong ZhouDepartment of Pharmacology, College of Pharmacy, the Third Military Medical University, Chongqing 400038, China.
Army Medical University · CNDaping Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Synthetic oligodeoxynucleotides containing unmethylated CpG dinucleotides (CpG ODN) function as potential radiosensitizers for glioma treatment, although the underlying mechanism is unclear. It was observed that CpG ODN107, when combined with irradiation, did not induce apoptosis. Herein, the effect of CpG ODN107 + irradiation on autophagy and the related signaling pathways was investigated. In vitro, CpG ODN107 + irradiation induced autophagosome formation, increased the ratio of LC3 II/LC3 I, beclin 1 and decreased p62 expression in U87 cells. Meanwhile, CpG ODN107 also increased LC3 II/LC3 I expression in U251 and CHG-5 cells. In vivo, CpG ODN107 combined with local radiotherapy induced autophagosome formation in orthotopic transplantation tumor. Investigation of the molecular mechanisms demonstrated that CpG ODN107 + irradiation increased the levels of TLR9 and p-ERK, and decreased the level of p-mTOR in glioma cells. Further, TLR9-specific siRNA could affect the expressions of p-ERK and autophagy-related proteins in glioma cells. Taken together, CpG ODN107 combined with irradiation could induce autophagic cell death, and this effect was closely related to the TLR9-ERK-mTOR signaling pathway in glioma cells, providing new insights into the investigation mechanism of CpG ODN.

Indexed as

AutophagyMAP Kinase Signaling SystemAnimalsBrain NeoplasmsCell Line, TumorCell SurvivalExtracellular Signal-Regulated MAP KinasesGene ExpressionGene Knockdown TechniquesGliomaHumansMice, NudeOligodeoxyribonucleotidesRadiation-Sensitizing AgentsToll-Like Receptor 9TOR Serine-Threonine KinasesCpG ODN107Extracellular Signal-Regulated MAP KinasesMTOR protein, humanOligodeoxyribonucleotidesRadiation-Sensitizing AgentsTLR9 protein, humanToll-Like Receptor 9TOR Serine-Threonine Kinases

Identifiers

PMID27251306
PMCPMC4890034
OpenAlexW2409739728

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.